HIGHLIGHTS
- What: The paper focuses on several key factors related to treatment including PD1/PDL1 EGFR and HER2 and explores their role in mAb therapy.
- Who: PD- and collaborators from the Shanxi Modern Bilingual School South Campus, Taiyuan, China have published the article: Development, applications, and future trends of monoclonal antibody therapy, in the : Proceedings of the 4th International Conference on Biological Engineering and Medical Science
- How: This paper proposes improvements in the production and cost of mAbs which can reduce costs while increasing the output.
- Future: In the section on the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.